Savitr Capital and Hayfin Capital Management led a $36m funding round in Glytic.

Investment firms Savitr Capital and Hayfin Capital Management led a $36m funding round in Glytic, a provider of an AI-powered technology platform. "This investment is a pivotal moment for Glytec, validating our vision of a future where deep data-driven insights empower clinicians to deliver highly individualized and proactive care for diabetes and metabolic conditions.Savitr Capital and Hayfin Capital share our belief in the transformative power of technology to improve patient outcomes and alleviate the burden of complex chronic diseases. This capital will enable us to expand our R&D initiatives, scale our platform, and continue to attract top-tier talent as we revolutionize metabolic healthcare," Patrick Cua, Glytec CEO.